We are live on ! Find out more
PROF

Profound Medical

34 hedge funds and large institutions have $79.2M invested in Profound Medical in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 14 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more capital invested

Capital invested by funds: $46.2M → $79.2M (+$33.1M)

60% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 5

10% more funds holding

Funds holding: 3134 (+3)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

1.39% less ownership

Funds ownership: 30.37%28.98% (-1.4%)

71% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 14

Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
8
Increased
4
Reduced
14
Closed
5
Calls
$3.45M
Puts
Net Calls
+$3.45M
Net Calls Change
+$1.42M

PROF Hedge Fund Activity: Q2 2020 in Review

34 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q2 2020, worth a combined $79.2M — up 72% from $46.2M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new PROF positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 14 trimmed.

The largest buyer was Zweig-DiMenna Associates, opening a new position worth an estimated $2.36M. The largest seller was EAM Global Investors, exiting entirely with an estimated $2.13M sold.

  • 34 institutional investors held Profound Medical (PROF) as of Q2 2020, up from 31 in Q1 2020.
  • Funds reported $79.2M of Profound Medical stock for Q2 2020, up 72% quarter-over-quarter.
  • 8 funds opened new Profound Medical positions in Q2 2020 and 5 closed out, a net change of +3 holders.
  • The largest Profound Medical buyer in Q2 2020 was Zweig-DiMenna Associates, an estimated $2.36M added.
  • The largest Profound Medical seller in Q2 2020 was EAM Global Investors, an estimated $2.13M sold.

Based on aggregated 13F filings for Q2 2020.